Clinical development of Modified Vaccinia virus Ankara vaccines.

Clinical development of Modified Vaccinia virus Ankara vaccines.

他のバージョン（1件）を表示する

The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...

書誌詳細
第一著者:	Gilbert, S
フォーマット:	Journal article
言語:	English
出版事項:	2013

類似資料

Clinical development of Modified Vaccinia virus Ankara vaccines
著者:: Gilbert, S
出版事項: (2013)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
著者:: Olga Vladimirovna Orlova, 等
出版事項: (2022-09-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
著者:: Gilbert, S, 等
出版事項: (1999)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
著者:: Moorthy, V, 等
出版事項: (2003)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
著者:: Kaïdre Bendjama, 等
出版事項: (2017-09-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
著者:: Volker Sandig, 等
出版事項: (2013-11-01)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
著者:: Juan García-Arriaza, 等
出版事項: (2021-08-01)

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
著者:: Alina Tscherne, 等
出版事項: (2024-11-01)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
著者:: López-Camacho, C, 等
出版事項: (2019)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
著者:: Alharbi, N
出版事項: (2014)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
著者:: César López-Camacho, 等
出版事項: (2019-11-01)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
著者:: Caroline Staib, 等
出版事項: (2003-04-01)

Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
著者:: Harriet L. Robinson, 等
出版事項: (2018-09-01)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
著者:: McConkey, S, 等
出版事項: (2003)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
著者:: Rosario, M, 等
出版事項: (2010)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
著者:: Flavia Chiuppesi, 等
出版事項: (2024-02-01)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
著者:: Mingwang Shen, 等
出版事項: (2024-10-01)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
著者:: Alharbi, N, 等
出版事項: (2015)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
著者:: C. Staib, 等
出版事項: (2000-06-01)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
著者:: Malachy I. Okeke, 等
出版事項: (2017-10-01)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.
著者:: Naif Khalaf Alharbi, 等
出版事項: (2015-01-01)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
著者:: Moorthy, V, 等
出版事項: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
著者:: Moorthy, V, 等
出版事項: (2003)

Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)
著者:: Schmidt, C, 等
出版事項: (2008)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
著者:: Behboudi, S, 等
出版事項: (2004)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
著者:: Schneider, J, 等
出版事項: (1998)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
著者:: Dorrell, L, 等
出版事項: (2000)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
著者:: Nereida Jiménez de Oya, 等
出版事項: (2022-03-01)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
著者:: Hanke, T, 等
出版事項: (1998)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
著者:: Cottingham, M, 等
出版事項: (2008)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified <i>Vaccinia virus</i> Ankara (MVA)
著者:: Maurilia Marcacci, 等
出版事項: (2020-07-01)

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
著者:: Ning Yang, 等
出版事項: (2022-10-01)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
著者:: Winslow, R, 等
出版事項: (2017)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
著者:: Matthew G Cottingham, 等
出版事項: (2008-02-01)

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
著者:: David A Garber, 等
出版事項: (2009-01-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
著者:: Goepfert P, 等
出版事項: (2012-09-01)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
著者:: McConkey, S, 等
出版事項: (2003)

Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model.
著者:: Miriam Nörder, 等
出版事項: (2010-01-01)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
著者:: Mcshane, H, 等
出版事項: (2001)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
著者:: Hanke, T, 等
出版事項: (2007)